Mechanica - About the company
Mechanica is an unfunded company. It operates as a Developer of biotechnology companies using computational biology, AI, and drug discovery. Mechanica has not raised any funding yet. The company has 848 active competitors, including 57 funded and 50 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.
Company Details
Developer of biotechnology companies using computational biology, AI, and drug discovery. It creates companies and builds shared infrastructure for drug discovery programs. The company takes advantage of the digitization of drug discovery.
Key Metrics
Sign up to download Mechanica's company profile
Mechanica's funding and investors
Mechanica has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mechanica's Competitors and alternates
Top competitors of Mechanica include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Mechanica, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Alloy Therapeutics 2017, Lexington (United States), Series E | Provider of drug discovery services | $157M | 63/100 | |
2nd |  Maiva Pharma 1996, Hosur (India), Late Stage | Manufacturer of sterile injectables | $125M | 61/100 | |
3rd |  Simulations Plus 1996, Lancaster (United States), Acquired | Developer of modeling and simulation software and consulting services provider | - | 60/100 | |
4th |  Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 54/100 | |
5th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 53/100 | ||
6th | Biotechnology research company developing biological drugs | $160M | 41/100 | ||
7th |  ArcaScience 2018, Paris (France), Seed | Developer of AI models for patient-centric insights in drug development | $7M | 52/100 | |
8th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
9th |  Arctoris 2016, Abingdon (United Kingdom), Seed | Provider of automated wet lab biology research and data generation services | $3.93M | 51/100 | |
10th |  Superluminal Medicines 2022, Boston (United States), Series A | Generative biological and chemical company focused on drug discovery | $158M | 38/100 | |
763rd |  Mechanica Unfunded | Developer of biotechnology companies using computational biology, AI, and drug discovery | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Mechanica's competitors? Click here to see the top ones
Mechanica's Investments and acquisitions
Mechanica has made no investments or acquisitions yet.
Reports related to Mechanica
Here is the latest report on Mechanica's sector:
Are you a Founder ?
FAQs about Mechanica
Explore our recently published companies
- ASU Pharma - Iraq based, Unfunded company
- Home With Bl - Toronto based, Unfunded company
- Golden Chain - Gothenburg based, 2023 founded, Unfunded company
- Berneron - Neuchatel based, 2022 founded, Unfunded company
- House of Glenfiddich - San Francisco based, Unfunded company
- MixMix - Chicago based, 2023 founded, Unfunded company
